NovaBay Pharmaceuticals, Inc. - NBY

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 23
Latest filed: Jun 17, 2026
Form Count
4 12
8-K 6
4/A 3
SCHEDULE 13D/A 2

Latest files

Filed Form Report period Accession SEC
Jun 17, 2026 4 Jun 15, 2026 0001437749-26-021026 View
Jun 17, 2026 4 Jun 15, 2026 0001437749-26-021025 View
Jun 17, 2026 4 Jun 15, 2026 0001437749-26-021024 View
May 19, 2026 4 Jan 16, 2026 0001437749-26-017857 View
May 19, 2026 4 Jan 16, 2026 0001437749-26-017856 View
May 19, 2026 4 Jan 16, 2026 0001437749-26-017855 View
Apr 30, 2026 4/A Oct 16, 2025 0001437749-26-014303 View
Apr 30, 2026 4/A Oct 16, 2025 0001437749-26-014302 View
Apr 30, 2026 4/A Oct 16, 2025 0001437749-26-014301 View
Apr 21, 2026 4 Mar 31, 2026 0001437749-26-012935 View
Apr 09, 2026 4 Mar 31, 2026 0001437749-26-011913 View
Apr 08, 2026 4 Mar 31, 2026 0001437749-26-011781 View
Apr 02, 2026 4 Mar 31, 2026 0001437749-26-011195 View
Apr 02, 2026 4 Mar 31, 2026 0001437749-26-011164 View
Mar 23, 2026 8-K Mar 23, 2026 0001437749-26-009301 View
Mar 12, 2026 8-K Mar 12, 2026 0001437749-26-008015 View
Mar 11, 2026 SCHEDULE 13D/A — 0001398344-26-005034 View
Feb 20, 2026 8-K Feb 20, 2026 0001437749-26-004922 View
Feb 12, 2026 8-K Feb 11, 2026 0001437749-26-003846 View
Jan 30, 2026 8-K Jan 30, 2026 0001437749-26-002586 View
Jan 29, 2026 SCHEDULE 13D/A — 0001829126-26-000773 View
Jan 29, 2026 4 Oct 21, 2025 0000921895-26-000165 View
Jan 28, 2026 8-K Jan 22, 2026 0001437749-26-002309 View